Skip to main content

Advertisement

SpringerLink
Log in

Microvessel density, endothelial-cell proliferation and carbonic anhydrase IX expression in haematological malignancies, bone-marrow metastases and monoclonal gammopathy of undetermined significance

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

The aim of the study was to compare the angiogenic status, potential qualitative differences in microvessels and carbonic anhydrase IX expression in bone-marrow (BM) metastases and different haematological tumours at time of diagnosis. The microvessel density (MVD), endothelial-cell proliferation (ECP) and carbonic anhydrase IX (CA IX) immunoreactivity were determined on 210 trephine biopsies from 57 patients with multiple myeloma (MM), 13 with acute myeloid leukaemia (AML), 48 with chronic myeloproliferative syndrome (CMPS), 26 with chronic lymphocytic leukaemia (CLL), 25 with epithelial BM metastases, 18 with monoclonal gammopathy of undetermined significance (MGUS) and from a control group composed of 23 patients without haematological neoplasm. There was an increased MVD and ECP in epithelial BM metastases, MM, AML, CMPS and in a part of CLL. While an ECP greater than 0 was detected in 72% of MM, 75% of CMPS and 92% of AML, it was invariably observed (100%) in the BM metastases. The absence of ECP together with a MVD comparable with the control group in our MGUS cases supports the view that MGUS is a pre-angiogenic condition. Qualitative differences in microvessels were associated with growth patterns in MM and CLL and were observed between the different entities of CMPS. In one-third of the epithelial BM metastases, there was a focal CA IX immunoreactivity, which was never observed in the haematological diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D, Koller C, Estrov Z, O’Brien S, Keating M, Freireich E, Albitar M (2000) Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 96:2240–2245

    CAS  PubMed  Google Scholar 

  2. Asosingh K, De Raeve H, Menu E, Van Riet I, Van Marck E, Van Camp B, Vanderkerken K (2004) Angiogenic switch during 5T2MM murine myeloma tumorigenesis, role of CD45 heterogeneity. Blood 103:3131–3137

    Article  CAS  PubMed  Google Scholar 

  3. Bartl R, Frisch B (1995) Diagnostic morphology in multiple myeloma. Current Diagn Pathol 2:222–235

    Google Scholar 

  4. Bartl R, Frisch B, Fatheh-Moghadam A, Kettner G, Jaeger K, Sommerfeld W (1987) Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am J Clin Pathol 2:222–235

    Google Scholar 

  5. Bertolini F, Mancuso P, Gobbi A, Pruneri G (2000) The thin red line: angiogenesis in normal and malignant hematopoiesis. Exp Hematol 28:993–1000

    Article  CAS  PubMed  Google Scholar 

  6. Chen J, Treweeke AT, West DC, Till KJ, Cawley JC, Zuzel M, Toh CH (2003) In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells. Blood 96:3181–3187

    Google Scholar 

  7. Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL (2001) Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 19:3660–3668

    CAS  PubMed  Google Scholar 

  8. Colpaert CG, Vermeulen PB, Fox SB, Harris AL, Dirix LY, Van Marck EA (2003) The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis. Breast Cancer Res Treatment 81:137–147

    Article  CAS  Google Scholar 

  9. Dankbar B, Padro T, Leo R, Feldmann B, Kropff M, Mesters RM, Serve H, Berdel WE, Kienast J (2000) Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood 95:2630–2636

    CAS  PubMed  Google Scholar 

  10. Dickson DJ, Shami PJ (2001) Angiogenesis in acute and chronic leukemias. Leuk Lymph 42:847–853

    CAS  Google Scholar 

  11. Friedler W, Graeven U, Ergün S, Verago S, Kilic N, Stockschläder M, Hossfeld D (1997) Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 89:1870–1875

    CAS  PubMed  Google Scholar 

  12. Harris AL (2002) Hypoxia—a key regulatory factor in tumour growth. Nature Rev 2:38–47

    Article  CAS  Google Scholar 

  13. Hashimotto N, Kurihara K (1982) A histological study on the developmental process of myeloma nodules. J Kyushu Hematol Soc 30:1–8

    Google Scholar 

  14. Hlatky L, Hahnfeldt P, Folkman J (2002) Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. J Natl Cancer Inst 94:883–893

    Google Scholar 

  15. Hussong JW, Rodgers GM, Shami PJ (2000) Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 95:309–313

    CAS  PubMed  Google Scholar 

  16. Kini AR, Day NE, Peterson LC (2000) Increased bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia 14:1414–1418

    CAS  PubMed  Google Scholar 

  17. Leppilampi M, Koistinen P, Savolainen ER, Hannuksela J, Parkkila AK, Niemelä O, Pastorekova S, Pastorek J, Waheed A, Sly WS, Parkkila S, Rajaniemi H (2002) The expression of carbonic anhydrase II in hematologic malignancies. Clin Cancer Res 8:2240–2245

    CAS  PubMed  Google Scholar 

  18. Loncaster JA, Harris AL, Davidson SE, Longue JP, Hunter RD, Wykoff CC, Pastorek J, Ratcliffe PJ, Stratford IJ, West CM (2001) Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61:6394–6399

    CAS  PubMed  Google Scholar 

  19. Lundberg LG, Lerner R, Sundelin P, Rogers R, Folkman J, Palmblad J (2000) Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. Am J Pathol 157:15–19

    CAS  PubMed  Google Scholar 

  20. Mesa RA, Hanson CA, Li C, Yoon SY, Schroeder GS, Tefferi A (2000) Bone marrow immunohistochemical features complement histology in distinguishing essential thrombocythemia from reactive thrombocytosis. Blood 96[Suppl]:S3214

  21. Moehler TM, Neben K, Ho AD, Goldschmidt H (2001) Angiogenesis in hematologic malignancies. Ann Hematol 80:695–705

    CAS  PubMed  Google Scholar 

  22. Molica S, Vacca A, Ribatti D, Cuneo A, Cavazzini F, Levato D, Vitelli G, Tucci L, Roccaro AM, Dammacco F (2002) Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. Blood 100:3344–3351

    Article  CAS  PubMed  Google Scholar 

  23. Munshi NC, Wilson C (2001) Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis. Semin Oncol 28:565–569

    Article  CAS  PubMed  Google Scholar 

  24. Padrò T, Ruiz S, Bieker R, Bürger H, Steins M, Kienast J, Büchner T, Berdel WE, Mesters RM (2002) Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 95:2637–2644

    Google Scholar 

  25. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J (1997) Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 150:815–821

    CAS  PubMed  Google Scholar 

  26. Rajkumar SV, Mesa RA, Fonseca R, Schroeder G, Plevak MF, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE, Gertz MA, Kyle RA, Russell SJ, Greipp PR (2002) Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Clin Cancer Res 8:2210–2216

    PubMed  Google Scholar 

  27. Stewart M, Talks K, Leek R, Turley H, Pezella F, Harris AL, Gatter K (2002) Expression of angiogenic factors and hypoxia factors HIF 1, HIF 2 and CA IX in non-Hodgkin’s lymphoma. Histopathology 40:253–260

    Article  CAS  PubMed  Google Scholar 

  28. Till KJ, Zuzel M, Cawley JC (1999) The role of hyaluronan and interleukin 8 in the migration of chronic lymphocytic leukemia cells with lymphoreticular tissues. Cancer Res 59:4419–4426

    CAS  PubMed  Google Scholar 

  29. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F (1994) Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 87:503–508

    CAS  PubMed  Google Scholar 

  30. Vacca A, Ria R, Semeraro F, Merchionne F, Coluccia M, Boccarelli A, Scavelli C, Nico G, Gernone A, Battelli F, Tabilio A, Guidolin D, Petrucci T, Ribatti D, Dammacco F (2003) Endothelial cells in the bone marrow of multiple myeloma. Blood 102:3340–3348

    Article  CAS  PubMed  Google Scholar 

  31. Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Beliën JAM, de Waal RMW, Van Marck E, Magnani E, Weidner N, Harris AL, Dirix LY (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38:1564–1579

    Article  CAS  PubMed  Google Scholar 

  32. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. New Engl J Med 324:1–8

    CAS  PubMed  Google Scholar 

  33. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60:7075–7083

    CAS  PubMed  Google Scholar 

  34. Wykoff CC, Beasley NJ, Watson PH, Campo L, Chia SK, English R, Pastorek J, Sly WS, Ratcliffe P, Harris AL (2001) Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol 158:1011–1019

    CAS  PubMed  Google Scholar 

  35. Xu JL, Lai R, Kinoshita T, Nakashima N, Nagasaka T (2002) Proliferation, apoptosis, and intratumoral vascularity in multiple myeloma: correlation with the clinical stage and cytological grade. J Clin Pathol 55:530–534

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Hilde Hellemans for helping with the immunostainings and Dr. Kewal Asosingh for his advice and encouragement. This work was supported by the Fund for Scientific Research—Flanders (Belgium) (F.W.O.-Vlaanderen) nr. G.0330.02. H.D.R. has a Clinical Doctoral Grant of F.W.O.-Vlaanderen and K.V. is a postdoctoral fellow of F.W.O.-Vlaanderen.

Author information

Authors and Affiliations

  1. University Hospital Antwerp, Department of Pathology, Wilrijkstraat 10, 2650, Edegem, Belgium

    H. R. De Raeve, P. B. Vermeulen & E. Van Marck

  2. Department of Haematology and Immunology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium

    K. Vanderkerken

  3. Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford , OX39DS, UK

    A. L. Harris

Authors
  1. H. R. De Raeve
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. B. Vermeulen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Vanderkerken
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. L. Harris
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Van Marck
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. R. De Raeve.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Raeve, H.R., Vermeulen, P.B., Vanderkerken, K. et al. Microvessel density, endothelial-cell proliferation and carbonic anhydrase IX expression in haematological malignancies, bone-marrow metastases and monoclonal gammopathy of undetermined significance. Virchows Arch 445, 27–35 (2004). https://doi.org/10.1007/s00428-004-1028-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-004-1028-y

Keywords

Search

Navigation